title: HDM2 protein overexpression and prognosis in primary malignant melanoma.
abstract: Overexpression of the oncogene HDM2 is observed in a substantial proportion of melanomas, including noninvasive and thin lesions, suggesting that HDM2 overexpression may be an early event in melanocyte transformation. To determine the role of HDM2 in the clinical progression of melanoma, we examined whether its expression was associated with patient survival. From November 1972 through November 1982, 134 patients with melanoma who participated in the New York University Melanoma Cooperative Group were studied, if representative tissues and follow-up were available. HDM2 protein expression was assessed immunohistochemically. Unexpectedly, we observed that HDM2 overexpression was statistically significantly associated with improved disease-free survival (relative risk [RR] = 0.47, 95% confidence interval [CI] = 0.24 to 0.89; two-sided chi(2) P =.021) and overall survival (RR = 0.55, 95% CI = 0.33 to 0.94; two-sided chi(2) P =.027) in multivariable analysis. HDM2 overexpression appears to be an independent predictor of survival for patients with primary melanoma; however, larger prospective studies are required for validation.
authors.affiliation: Department of Dermatology, Medical Center, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
authors.forename: David
authors.initials: D
authors.lastname: Polsky
authors.forename: Kate
authors.initials: K
authors.lastname: Melzer
authors.forename: Carole
authors.initials: C
authors.lastname: Hazan
authors.forename: Katherine S
authors.initials: KS
authors.lastname: Panageas
authors.forename: Klaus
authors.initials: K
authors.lastname: Busam
authors.forename: Maria
authors.initials: M
authors.lastname: Drobnjak
authors.forename: Hideko
authors.initials: H
authors.lastname: Kamino
authors.forename: Joanna G
authors.initials: JG
authors.lastname: Spira
authors.forename: Alfred W
authors.initials: AW
authors.lastname: Kopf
authors.forename: Alan
authors.initials: A
authors.lastname: Houghton
authors.forename: Carlos
authors.initials: C
authors.lastname: Cordon-Cardo
authors.forename: Iman
authors.initials: I
authors.lastname: Osman
mesh_terms: D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D008545:Melanoma / Q000737:chemistry* / Q000473:pathology; D008875:Middle Aged; D015999:Multivariate Analysis; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D051736:Proto-Oncogene Proteins c-mdm2; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology; D015854:Up-Regulation
chemical_list: D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2